Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...